387283005: Prazosin hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with adrenergic receptor antagonist mechanism of action (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Prazosin hydrochloride (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Alpha adrenergic receptor antagonist\Alpha-1 adrenergic receptor antagonist\Prazosin hydrochloride (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Cardiovascular agent (substance)\Hypotensive agent (substance)\Vasodilator (substance)\Prazosin hydrochloride (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Prazosin hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Prazosin hydrochloride (substance)	Is a	Prazosin (substance)	false	Inferred relationship	Some
Prazosin hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-1 adrenergic receptor antagonist (disposition)	true	Inferred relationship	Some
Prazosin hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Prazosin (substance)	true	Inferred relationship	Some
Prazosin hydrochloride (substance)	Is a	Alpha-1 adrenergic receptor antagonist	true	Inferred relationship	Some
Prazosin hydrochloride (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Prazosin hydrochloride (substance)	Is a	Alpha adrenergic receptor antagonist	false	Inferred relationship	Some
Prazosin hydrochloride (substance)	Is a	Vasodilator (substance)	true	Inferred relationship	Some
Prazosin hydrochloride (substance)	Is a	Autonomic agent (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing prazosin hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Prazosin hydrochloride 500micrograms + 1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Prazosin (as prazosin hydrochloride) 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely prazosin hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely prazosin hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Prazosin hydrochloride 1 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Polythiazide + prazosin hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some
Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Prazosin (as prazosin hydrochloride) 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Prazosin hydrochloride 1 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Prazosin hydrochloride 1 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Prazosin (as prazosin hydrochloride) 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin hydrochloride 2 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Prazosin hydrochloride 1 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1
Prazosin (as prazosin hydrochloride) 5 mg prolonged-release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Prazosin hydrochloride (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461461018	Prazosin hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481384017	Prazosin hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491971015	Furazosin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
29251000188115	prazosine chlorhydrate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
835431000172110	chlorhydrate de prazosine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module